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Abstract: Lectin-like oxidized LDL receptor-1 (LOX-1) is an endothelial receptor for
oxidized LDL (oxLDL) and plays multiple roles in the development of cardiovascular diseases. We
screened more than 400 foodstuﬀ extracts for identifying materials that inhibit oxLDL binding to
LOX-1. Results showed that 52 extracts inhibited LOX-1 by more than 70% in cell-free assays.
Subsequent cell-based assays revealed that a variety of foodstuﬀs known to be rich in procyanidins
such as grape seed extracts and apple polyphenols, potently inhibited oxLDL uptake in Chinese
hamster ovary (CHO) cells expressing LOX-1. Indeed, puriﬁed procyanidins signiﬁcantly inhibited
oxLDL binding to LOX-1 while other ingredients of apple polyphenols did not. Moreover, chronic
administration of oligomeric procyanidins suppressed lipid accumulation in vascular wall in
hypertensive rats fed with high fat diet. These results suggest that procyanidins are LOX-1
inhibitors and LOX-1 inhibition might be a possible underlying mechanism of the well-known
vascular protective eﬀects of red wine, the French Paradox.
Keywords: LOX-1, cardiovascular diseases, lipid accumulation, procyanidin, French
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Introduction
Atherosclerosis is a leading burden of cardiovas-
cular diseases such as coronary artery diseases and
stroke. It is a chronic, multifactorial disease of
vascular wall involving lipid accumulation, inﬂam-
mation, cell death, and thrombosis. The changes in
the vascular wall, which precede by far earlier the
appearance of coronary artery diseases.1),2) Environ-
mental factors such as diet and cigarette smoking
together with such pathological conditions as hyper-
lipidemia, hypertension and diabetes greatly inﬂu-
ence the disease progression over time. Therefore,
lifestyle changes such as diet control and smoking
cessation are strongly encouraged in patients with
high risk of cardiovascular diseases.
Lectin-like oxidized receptor-1 (LOX-1) was
originally identiﬁed as an endothelial receptor for
oxidized LDL (oxLDL), a critical player involved in
the initiation of atherosclerosis.3) OxLDL binds to
LOX-1 and increases expressions of adhesion mole-
cules and inﬂammatory cytokines, and decreases
nitric oxide release, resulting in endothelial dysfunc-
tion.4)–6) LOX-1 also recognizes other ligands such
as platelets and C-reactive protein, and mediates
platelet adhesion and vascular hyperpermeability,
respectively.7),8) LOX-1 is expressed not only in
endothelial cells but in macrophages, vascular
smooth muscle cells, platelets and cardiomyocytes;
and the expression is highly induced under athero-
genic settings such as hyperlipidemia, hypertension
and diabetes.9)–11) In vivo evidence has also demon-
strated that LOX-1 contributes to the initiation
and development of a wide range of cardiovascular
diseases. For instance, LOX-1 gene-deﬁcient mice
display less atherosclerotic lesions on high fat diet
and less myocardial injury after ischemia-reperfu-
sion.12),13) Conversely, LOX-1 overexpressing mice
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endothelium-dependent vasorelaxation on high fat
diet.14),15) Importantly, we have recently demon-
strated that high LOX Index, which is calculated
by multiplying circulating concentrations of soluble
LOX-1 and LOX-1 ligand LDL, associates with an
increased risk of coronary heart diseases and stroke
in Japanese population.16) These lines of evidence
suggest that inhibition of LOX-1 could be a strategy
for the prevention and/or treatment of cardiovascu-
lar diseases.
Although statin therapy has made a success to
reduce the risk of cardiovascular events, multiple
lines of evidence have suggested that daily intake
of certain foods or beverages could be an eﬀective
strategy to prevent the development of cardiovascu-
lar diseases. For instance, ﬁsh oil and red wine have
been long postulated to possess cardioprotective
actions.17),18) Moreover, a case–control study involv-
ing participants from 52 countries reported an
inverse association between the risk of myocardial
infarction and intake of prudent diet (high in fruit
and vegetables).19) However, the molecular targets
and/or the active ingredients of those foods and
beverages are largely unknown although a number of
health food supplements are available in the market.
This study was undertaken to identify materials that
inhibit oxLDL binding to LOX-1 from foodstuﬀ
extracts.
Materials and methods
Preparation of lipoproteins. Serum was
isolated from healthy volunteers and LDL (density:
1.019–1.063g/mL) was prepared by sequential ultra-
centrifugation. Isolated LDL was oxidized with
7.5µM CuSO4 for 16h and labeled with 1,1-diocta-
decyl-3,3,3,3-tetramethylindocarbocyanine perchlo-
rate (DiI, Invitrogen, Carisbad, CA, USA) (DiI-
oxLDL) as described previously.3)
Preparation of procyanidins. Procyanidins
were separated and puriﬁed from apple polyphenols
as previously described20),21) and lyophilized until
use.
Primary screening in LOX-1 ELISA. 437
foodstuﬀ extracts and 35 test reagents stored in
Asahi Breweries, Ltd. were used for the screening.
Powdery foodstuﬀ extracts were collected by micro
spatula, dissolved in 1mL DMSO and centrifuged to
remove the unsolved fraction. The solutions were
diluted 50-fold in 10mM HEPES buﬀer containing
5% bovine serum albumin and 2mM ethylenedi-
aminetetraacetic acid (EDTA). They were mixed
with oxLDL to the ﬁnal concentration of oxLDL at
1µg/mL and were added to 384-well plate (Greiner,
Frickenhausen, Germany) coated with human
LOX-1 (61-273, aa). OxLDL binding to LOX-1 was
determined using horseradish peroxide (HRP)-con-
jugated sheep anti-human apoB (The Bindingsite,
Birmingham, UK) as previously reported.16) OxLDL
binding was expressed as a ratio of the binding in the
presence of foodstuﬀ extracts to that in the presence
of vehicle alone. The ﬁnal concentration of DMSO
was less than 0.5% of total volume.
Secondary screening in CHO cells expressing
LOX-1. Tetracycline-inducible human LOX-1
(tagged with V5-6#His at C-terminus) expressing
CHO-K1 (LOX-1-CHO) cells were maintained as
previously described.8) The cells were seeded in
96-well plate at 104cells/well in the presence of
doxycycline (1µg/mL) (Calbiochem, La Jolla, CA,
USA) and were incubated in Ham’s F-12 medium
containing 10% FBS at 37°C for 24h. After being
washed with the medium without FBS, the cells were
treated with foodstuﬀ extracts or an anti-LOX-1
antibody at the ﬁnal concentration of 10µg/mL for
1h. The cells were washed again and incubated with
DiI-oxLDL (10µg/mL) for 2h. After washing, the
cells were ﬁxed with 10% formalin, and were stained
with 4′,6-diamidino-2-phenylindole (DAPI) (Sigma,
St. Louis, MO, USA). The binding of DiI-oxLDL to
LOX-1-CHO cells were determined similarly to the
uptake assay, except that the incubation of DiI-
oxLDL was performed at 4°C for 45min. The samples
were subjected to ﬂuorescence microscopic analysis
(Axiovert 200M, Zeiss, Oberkochen, Germany) or
quantitative ﬂuorescence analysis using the IN
Cell analyzer system (GE Healthcare, Fairﬁeld, CT,
USA). Cell-associated DiI-oxLDL was determined as
a ratio of DiI-oxLDL ﬂuorescence intensity per cell in
the presence of foodstuﬀ extracts to that in the
absence of extracts. All experiments were conducted
in more than triplicates. For the determination of
ﬂuorescence quenching by procyanidins, the ﬂuores-
cence was also measured before washing out unbound
DiI-oxLDL (Spectramax, Molecular Devices, Sunny-
vale, CA, USA). The ﬁnal concentration of DMSO
was less than 0.1% of total volume.
Animal study. All protocols were approved by
the Institutional Animal Care and Use Committee
of the National Cerebral and Cardiovascular Center.
Animals were individually housed at 23 ’ 2°C with
12h light-dark cycles (7:00–19:00 light-on). Eight-
week-old male stroke-prone spontaneously hyper-
tensive rats (SHR-SP) (CLEA Japan, Tokyo, Japan)
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similar blood pressure, heart rates and body weights
(tail cuﬀ and pulse transducer system, BP-98A,
Softron, Tokyo, Japan). They were given high fat
diet without cholic acid or vitamin E (CLEA Japan,
Tokyo, Japan) and physiological saline as drinking
water for 2 weeks. Half of the rats received
physiological saline containing 0.5%(w/v) oligomeric
procyanidins (OPC) with various chain lengths
puriﬁed from apples. At the end of the study, the
rats were euthanized with isoﬂurane inhalation and
blood was collected from vena cava between 11:00–
14:00. The rats were perfused systemically with
physiological saline for Oil Red O staining. Total
cholesterol, high-density lipoprotein (HDL) choles-
terol, triglyceride, and thiobarbituric acid reactive
substance (TBARS) were determined enzymatically
using commercially available kits (Wako Pure
Chemical Industries, Osaka, Japan; Zeptometrix
corporation, Buﬀalo, NY, USA). In a separate
experiment, rats (n F 4) were given 0.5% OPC for
two days and similarly sacriﬁced between 7:00–8:00
for the determination of plasma concentrations of
epicatechin(4O-8)epicatechin (procyanidin B2) and
epicatechin(4O-8)epicatechin(4O-8)epicatechin (pro-
cyanidin C1) as previously reported.20)
Oil Red O staining of accumulated lipid in
mesenteric arteries. Oil Red O staining was used
for the detection of lipid accumulation in mesenteric
arteries as previously reported.22) In brief, the intestine
was excised out and the enteric canal was removed.
Branches of the mesenteric artery were isolated from
adipose tissue and ﬁxed with 10% formalin. The
mesenteric arteries were incubated in 60% isopropanol
for ﬁve minutes followed by staining with 0.18%
Oil Red O (Merck KGaA, Darmstadt, Germany).
Lipid deposits were manually enumerated under
stereomicroscope in the posterior 8 branches of the
artery(Stemi2000,CarlZeiss,Oberkochen,Germany).
Anti-LOX-1 antibody. A monoclonal anti-
body against human LOX-1 (TS92) was used for
blocking ligand binding to LOX-1. Characteristics of
the antibody were described in previous reports.7),23)
Statistics. One-way ANOVA followed by
Dunnett or Student’s t-test was performed for
multiple or paired comparison, respectively. P <
0.05 was considered statistically signiﬁcant and
indicated by *.
Results
Screening. 472 products were investigated to
identify LOX-1 inhibitors. They included 437 food-
stuﬀ extracts and 35 test reagents such as amino
acids. Almost all the products were commercially
available and many of them have been utilized for
healthcare as folk medicine or health food supple-
ments. The assayed products were categorized as
shown in Fig. 1.
First we employed a sandwich ELISA using
oxLDL as a ligand for LOX-1. Results showed that
52 products inhibited oxLDL binding by more than
70% (data not shown). The products were further
examined using a cell-based assay whether they
inhibited oxLDL uptake in LOX-1-CHO cells. Con-
trol CHO cells did not uptake DiI-labeled oxLDL
(DiI-oxLDL) at detectable levels, indicating the
speciﬁc uptake of DiI-oxLDL by LOX-1 (data not
shown). In LOX-1-CHO cells, we found 26 products
that inhibited DiI-oxLDL uptake by more than 70%
(Table 1). These included a number of foodstuﬀ
extracts that are known to contain a large amount
of procyanidins such as grape seed extracts, pine
bark extracts, peanuts skin and apple polyphenols
(highlighted in bold, Table 1). We considered the
possibility that procyanidins may inhibit oxLDL
binding to LOX-1 and conducted the subsequent
studies.
Characterization of apple polyphenols. In
the next series of experiments, we characterized
the proﬁles of apple polyphenols as a representative
containing a large amount of procyanidins. Apple
polyphenols dose-dependently and completely inhib-
ited the DiI-oxLDL (10µg/mL) binding to LOX-1-
CHO cells with an IC50 value of 102ng/mL (Fig. 2A).
As apple polyphenol contains catechin/epicatechin
((epi)catechin), phenolcarboxylic acids, and other
ingredients as well as procyanidins (Fig. 2B), we
examined which of the ingredients inhibited DiI-
oxLDL binding to LOX-1. As shown in Fig. 2C, the
fractions containing procyanidins and (epi)catechin
signiﬁcantly inhibited the DiI-oxLDL binding while
phenolcarboxylic acids and others did not. These
results clearly indicated that procyanidins and/or
(epi)catechin were active ingredients for the inhib-
ition of oxLDL binding to LOX-1. Neither apple
polyphenol nor procyanidins displayed cytotoxic
eﬀects up to 10µg/mL (data not shown).
In vitro proﬁles of procyanidins. We next
analyzed the activities of procyanidins according to
the polymerization levels. (Epi)catechin and oligo-
meric procyanidins from dimer to heptamer were
separated from apple polyphenols as previously
reported.20),21) Puriﬁed procyanidins were used for
the analysis. The results showed that procyanidins of
T. NISHIZUKA et al. [Vol. 87, 1066dimer displayed a concentration-dependent inhib-
ition of DiI-oxLDL (10µg/mL) binding to LOX-1-
CHO cells. In contrast, (epi)catechin was without
eﬀect up to 1µg/mL (Fig. 3). Moreover, the eﬃcacy
was much more potent with procyanidin of 6trimer
than dimer procyanidin. The IC50 of dimer procya-
nidin was 330ng/mL and that of oligomeric procya-
nidins ranged from 61ng/mL (trimer) to 27ng/mL
(heptamer). Oligomeric procyanidins with chain
length of more than eight also similarly inhibited
oxLDL binding (data not shown). These results
clearly indicated that oligomeric procyanidins inhib-
ited oxLDL binding to LOX-1.
It has been reported that trimer apple procyani-
dins comprises six isoforms.21) In the next study, we
prepared major four isomers of apple procyanidins,
epicatechin(4O-8)epicatechin(4O-8)epicatechin (known
as procyanidin C1), epicatechin(4O-8)epicatechin(4O-
8)catechin, epicatechin(4O-6)epicatechin(4O-8)cate-
chin and epicatechin(4O-6)epicatechin(4O-8)epicate-
chin, and examined their activities. As shown in
Fig. 4A, the ﬂuorescence of DiI-oxLDL (10µg/mL)
in LOX-1-CHO cells was signiﬁcantly attenuated by
procyanidin C1 (300ng/mL). The ﬂuorescence repre-
sents the speciﬁc binding to LOX-1 since it was
disrupted by anti-LOX-1antibody (LOX-1 Ab). These
results indicated that procyanidin C1 inhibited oxLDL
binding to LOX-1. Quantitative analysis showed that
all of the trimer procyanidins similarly inhibited DiI-
oxLDL binding to LOX-1-CHO cells with IC50so f
51, 41, 47 and 73ng/mL, respectively (Fig. 4B). The
ﬂuorescence quenching of DiI-oxLDL by procyani-
din C1 (300ng/mL) was less than 25% (data not
(A)
(B)
(C)
Procyanidins (Epi)catechin
Phenolcarboxylic acids Others
Fig. 2. DiI-oxLDL (10µg/mL) binding in LOX-1-CHO cells in
the presence of apple polyphenols (A) and each ingredient of
apple polyphenols (C, 100ng/mL each). Figure 2B represents
the relative contents of each ingredient in apple polyphenols.
The graph was created according to the reference.20) * represents
statistical signiﬁcance from control.
Fig. 1. Products assayed in ELISA were categorized according to
the origins of foodstuﬀ; plant-derived products, yeast extracts,
milk products, ﬁsh products, insect products, mushroom, algae
and others. The plant-derived products were further classiﬁed by
the parts used. The number in parenthesis indicates the number
of the assayed products.
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7ng/mL and 26ng/mL when DiI-oxLDL was used at
the concentrations of 1 and 3µg/mL, respectively
(data not shown).
In vivo eﬀects of oligomeric procyanidins.
Finally, we addressed whether procyanidins inhibited
lipid accumulation in vascular wall in vivo. Oligo-
meric procyanidins (OPC), a mixture containing
procyanidins with various chain lengths puriﬁed from
apple, was used for in vivo study. SHR-SP rats are
well-known disease-model animals for hypertension
and stroke, and accumulate lipids in arterial wall in
response to high fat diet.22),24) In this study, 8 week
old SHR-SP rats were given high fat diet and
physiological saline containing 0.5% OPC (OPC
rats) for 2 weeks. OPC did not aﬀect the daily food
intake and body weight during the experimental
period. Systolic and diastolic blood pressure and
heart rates were also unaﬀected (Table 2). At
termination, the mesenteric artery isolated from the
control rats displayed numerous Oil Red O-positive
dots while that from the OPC-treated rats displayed
signiﬁcantly less dots, indicating that OPC sup-
pressed arterial lipid deposition (Fig. 5). Plasma
total cholesterol (TC), HDL-cholesterol, triglyceride
and TBARS did not diﬀer between the groups
(Table 2). The plasma concentrations of procyani-
din B2 and C1 in OPC rats were 7.9 ’ 1.8ng/mL
and 4.9 ’ 1.9ng/mL, respectively.
Discussion
We successfully identiﬁed several foodstuﬀ ex-
tracts that inhibit LOX-1 using ELISA and DiI-
oxLDL uptake assay. The results obtained with the
cell assays suggested that procyanidins might be one of
the components that inhibit oxLDL uptake since
nearly half of the potent hit extracts are known to
contain a large amount of procyanidins. Indeed,
puriﬁed procyanidins inhibited oxLDL binding in
LOX-1-CHO cells. Moreover, OPC suppressed lipid
accumulation in vascular wall of SHR-SP rats in which
an anti-LOX-1 antibody was also eﬀective.22) To date,
several natural products with cardioprotective eﬀects
Fig. 3. DiI-oxLDL (10µg/mL) binding in LOX-1-CHO cells in
the presence of diﬀerent levels of polymerized procyanidins. The
results of procyanidins 6 pentamer are omitted from the graph
for clarity.
Table 1. Foodstuﬀ extracts (10µg/mL) that showed more than
70% inhibition in DiI-oxLDL uptake in LOX-1-CHO cells.
Similar foodstuﬀ extracts sold by multiple suppliers were assayed
as diﬀerent extracts since the extraction methods are diﬀerent
or are not speciﬁed. As a result, similar extracts are listed in the
table such as grape seed extract. Those extracts are attached
with superscript numbers and the suppliers are shown at the
bottom. Products known to be rich in procyanidins are shown in
bold.
Extract/Product Name Inhibition (%)
Black Soybean Hull 99
Propolis 98
Oligomoeric Proanthocyanidins
from Grape Seed*1 98
Grape Seed*2 98
Peanut Seed Coat*3 98
Apple Condensed Tannin 97
Grape Seed*4 97
Peanut Seed Coat*5 97
French Maritime Pine Bark 96
Proanthocyanidins 95
New Zealand Pine Bark 95
Grape Seed*6 91
Apple Polyphenol 88
Pomegranate Skin 86
Rooibos Tea 86
Mangosteen Fruit Skin 84
Wasabi Leaf 83
Gingko Leaf 80
Bilberry*7 80
Bilberry*8 78
Guava Leaf 76
Vitis Coignetiae 76
Quercus Salicina 76
Pine Bark 75
Hop Polyphenol 73
Cat’s Claw 72
*1Kikkoman, *2Sun Globe Food, *3Kishimoto Sangyo,
*4Hoechst Marion Roussel, *5Tokiwa Phytochemical, *6Chika
Industries, *7Indena Japan, *8Tokiwa Phytochemical.
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Fig. 4. DiI-oxLDL (10µg/mL) binding in LOX-1-CHO cells in the presence of various isomers of trimer procyanidins. Fluorescent
images of DiI-oxLDL (red) binding to LOX-1-CHO cells in the absence or presence of procyanidin C1 (300ng/mL) or in the presence
of anti-LOX-1 antibody (A). Nuclei were stained by DAPI (blue). DiI-oxLDL binding in LOX-1-CHO cells in the presence of various
concentrations of trimer procyanidin isomers (B). Chemical structures of the trimer procyanidin isomers used in the experiments are
shown. Diﬀerence in the hydroxyl groups indicated by red jagged lines causes stereoisomers of catechin and epicatechin.
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oxLDL and/or the expression of LOX-1 such as
ﬂavonoids from seabuckthorn, bergamot oil and
mulberry leaf aqueous fractions.25)–27) However, their
molecular targets are not known. To our knowledge,
this is the ﬁrst report demonstrating a direct
antagonistic action of natural products to LOX-1.
LOX-1-inhibiting properties were almost identi-
cal among procyanidins 6 trimer and the dimer also
potently inhibited LOX-1. Moreover, four diﬀerent
isomers of trimer procyanidins almost equally in-
hibited oxLDL binding to LOX-1. These results
implicate that intake of procyanidin-rich foods
potentially inhibits LOX-1, regardless of food source
since the polymerization levels of procyanidins
signiﬁcantly diﬀer among foods.28) In support to this,
OPC, a mixture of various chain lengths of procya-
nidins, inhibited vascular lipid accumulation in SHR-
SP rats. We have previously demonstrated that an
anti-LOX-1 antibody inhibited vascular lipid accu-
mulation in this animal model,22) suggesting that
procyanidins function as a LOX-1 inhibitor in in vivo
as well. A wide range of in vivo eﬀects of procyanidin-
Table 2. Body weight, cardiovascular parameters, food intake
and plasma parameters of SHR-SP rats before and after the
administration of procyanidins (OPC).
Parameters
Control OPC
Before After Before After
Body Weight (g) 198 ’ 5 247 ’ 4 199 ’ 5 237 ’ 4
Systolic Blood
Pressure (mmHg)
173 ’ 7 191 ’ 6 174 ’ 4 197 ’ 3
Diastolic Blood
Pressure (mmHg)
119 ’ 6 137 ’ 3 121 ’ 3 142 ’ 4
Heart Rate (/min) 351 ’ 7 348 ’ 5 364 ’ 8 364 ’ 7
Food Intake (g/day) 18.0 ’ 0.4 17.1 ’ 0.3
Plasma Triglyceride
(mg/dL)
404.8 ’ 45.3 378.2 ’ 46.1
Total Cholesterol
(mg/dL)
157.6 ’ 8.4 152.3 ’ 6.4
HDL-cholesterol
(mg/dL)
36.1 ’ 1.6 35.6 ’ 0.9
TBARS (nmol/mL) 0.89 ’ 0.05 0.84 ’ 0.04
(A)
(B)
500µm Control OPC
Fig. 5. Arterial lipid deposition in SHR-SP rats on high fat diet. Oil Red-O image (A) and the number of lipid deposition (B) in control
and OPC rats. * represents statistical signiﬁcance from control.
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sive and anti-hyperlipidemic actions have been
reported.29)–32) These actions potentially reduce
vascular lipid accumulation, since in this animal
model vascular lipid accumulation is increased by
high fat feeding and decreased by the treatment with
anti-oxidant or hypotensive agents22) (unpublished
observation). It may be less likely, however, since
OPC did not aﬀect cardiovascular parameters,
plasma lipids, or TBARS, a marker of oxidative
state, in the present study. Diﬀerent experimental
conditions such as dosage and experimental period
may have aﬀected the readouts. Shoji et al. have
demonstrated that procyanidin B2 and C1 are orally
available.20) In agreement to this, we were able to
detect procyanidin B2 and C1 in the plasma of rats
treated with orally administered OPC. However, the
plasma levels of procyanidins were small and close to
the detection limits. These results may argue against
that OPC suppressed vascular lipid accumulation by
inhibiting LOX-1 on vascular wall. Yet, the plasma
level may be suﬃcient to inhibit LOX-1 since plasma
oxLDL level in SHR-SP rats is about 200ng/mL22)
and procyanidin C1 halved the oxLDL binding in
LOX-1-CHO cells even at 7ng/mL when 1µg/mL
oxLDL was used. Alternatively, plasma procyanidin
levels may have reached higher when rats actively
intake OPC during light-oﬀ period. It is also possible
that OPC may inhibit the function of LOX-1
expressed on the apical membrane of intestinal
epithelium, in which LOX-1 mediates the trans-
cytosis of bile salt-dependent lipase.33) Since intesti-
nal lumen is exposed to a signiﬁcant amount of OPC
during the absorption process, OPC may have
inhibited intestinal LOX-1 and thereby modulated
lipid metabolism leading to less lipid accumulation.
Further studies are deﬁnitely called for to reach
positive evidences to determine whether OPC inhib-
its LOX-1 in vivo or other unknown factors might be
involved.
Out of more than 400 foodstuﬀ extracts derived
from various sources, more than half of those
displaying potent LOX-1 inhibition are known to
contain a large amount of procyanidin. In addition,
not well-known compared to apples or grape seeds,
procyanidins are also contained in other extracts
listed in Table 1 such as pomegranate skin,34)
mangosteen fruit skin,35) bilberry,36) Quercus salici-
na37) and cat’s claw.38) These results implicate that
LOX-1 inhibition may underlie the health beneﬁts of
these extracts. Of particular interest, procyanidins
as well as resveratrol are considered to be one of the
bioactive ingredients in red wine for the cardiopro-
tective eﬀects, known as “French Paradox”.39)–41) The
present ﬁndings implicate that LOX-1 is a molecular
target of procyanidins as is sirtuin 1 for resveratrol.
Furthermore, Corder et al. identiﬁed procyanidins
from red wine as the molecule that suppressed
endothelin-1 release from vascular endothelial
cells.42),43) They also found that the concentrations
of procyanidins were high in wines from certain
geographic areas, which correlated with longevity
in such regions.42),43) As LOX-1 activation leads to
endothelin-1 release from endothelial cells,44) these
results may further support the hypothesis that
LOX-1 inhibition is an underlying mechanism of
the cardiovascular protective eﬀects of red wine.
In conclusion, we demonstrate that LOX-1-
inhibiting property is rich in foodstuﬀs containing a
large amount of procyanidins and that procyanidins
are potent inhibitors of LOX-1. These results
implicate the role of LOX-1 in the French Paradox.
Moreover, the LOX-1 ELISA and CHO cell assays
employed in this study are likely to make powerful
methods to identify LOX-1 inhibitors not only from
foodstuﬀs but also from chemical compounds for
future drug discovery.
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